Androgen Receptor and Invasion in Prostate CancerTakahito Hara, Robert E. Reiter, Hideyo Miyazaki et al.|Cancer Research|2008Cited by 115
Physical, but not laboratory, treatment‐related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysisSatoru Taguchi, Haruki Kume, Keigo Sato et al.|International Journal of Urology|2024Cited by 4
Development of risk-score model in patients with negative surgical margin after robot-assisted radical prostatectomyYuta Yamada, Haruki Kume, Yoichi Fujii et al.|Scientific Reports|2024Cited by 4
Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysisSatoru Taguchi, Haruki Kume, Taketo Kawai et al.|Research Square|2024Cited by 2
Supplementary Figures 1-2 from Androgen Receptor and Invasion in Prostate CancerTakahito Hara, Robert E. Reiter, Hideyo Miyazaki et al.|Unknown|2023Cited by 0